Menu
Recruiting NCT03371121

Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

No phase Interventional Talar Osteochondral Defect of Ankle Pain Arthroscopy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis).
Who it may be relevant to
Registry conditions: Talar Osteochondral Defect of Ankle, Pain, Arthroscopy. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Valutazione Dell'Epidemiologia e Dei Risultati Radiografici e Clinici Nel Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

Overview

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions

Interventions

  • Other AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)
    to fill arthroscopically osteochondral talar lesion

Primary outcome measures

  • Radiologic reduction of the lesion [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Age over 18 years
  • males and females
  • patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus

Exclusion criteria

  • age <18 years at the time of surgery
  • patients with previous surgery on the affected ankle

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Italy · 1 center
  • Federico Usuelli — Milan

Identifiers

NCT: NCT03371121 · AMIC

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗